Poster Instructions and Assignment List
Transcription
Poster Instructions and Assignment List
POSTER, STUDENT POSTER, CLINICAL VIGNETTE POSTER, AND INNOVATION ACADEMY POSTER PRESENTATION INSTRUCTIONS POSTER Viewing: Location: Thursday, April 16 and Friday, April 17 Coles Ballroom (PEI Convention Centre) Viewing Times Thursday April 16: Morning break 11:00 am to 12:30 pm o STUDENT POSTER PRESENTERS (SP) MUST BE AT THEIR POSTERS TO ANSWERS QUESTIONS! Lunch between 12:30 pm to 1:00 pm Welcome Reception 6:30 pm to 8:30 pm Viewing Times Friday April 17: Morning break 11:00 am to 12:30 pm o POSTER (P), CLINICAL VIGNETTE (CV), AND INNOVATION ACADEMY (IA) POSTER PRESENTERS MUST BE AT THEIR POSTERS TO ANSWERS QUESTIONS! Lunch between 12:30 pm to 1:00 pm Poster Set-Up Time: Wednesday April 15 between 4:00 pm – 6:00 pm Thursday April 16 between 7:00 am – 10:00 am Poster Removal Time: Friday April 17 at 1:00 pm * Should you require assistance onsite, please go to the Registration Desk. GENERAL INFORMATION Poster Boards are 4ft high x 8ft wide. A good poster size is 3ft high x 6ft wide. Velcro (male side) and pin friendly. All presenting authors MUST be registered for the annual conference, no later than Monday March 2, 2015. If registration is not complete by this date, the abstract will be REMOVED and will NOT be published. STUDENT POSTER Presenters must fill in and submit to (communications@ammi.ca) a Student/Technologist/Trainee Awards Competition Form by Monday March 2, 2015. http://ammi.ca/media/75949/Student-TechnologistTrainee%20Award%20Form%20-%20EN%20v2.pdf HOTEL AND CONFERENCE REGISTRATION INFORMATION The Hotel Room Blocks are full at both the Delta Prince Edward and Holman Grand. Please contact Stephanie Wolkowycki at the AMMI Canada Secretariat at info@ammi.ca to make arrangements. REGISTRATION Register now: http://ammi.emsreg.com/ammi15/public/splash1.aspx STUDENT POSTER PRESENTATION ASSIGNMENT LIST Serial No. Prog. No. 0003 SP01 0004 SP02 Initial Bahareh Last name Ghadaki Title COPD Symptom and Disease Screening in an HIV Population Withdrawn 0007 SP03 Gabriel Chan 0021 SP04 Chris Lata 0026 SP05 Hong Yuan Zhou 0028 SP06 Ramzi Fattouh 0031 SP07 Nipunie Rajapakse 0035 SP08 Roshan Priyantha 0036 SP09 Anthony Bai 0040 SP10 Carla Penney 0045 SP11 Jasmine Chong 0046 SP12 Sylvain Lother 0047 SP13 Manal Rostom 0048 SP14 0049 SP15 Mohammad Alghounaim 0051 SP16 Sumana Fathima 0052 SP17 Nathan Zelyas 0056 SP18 Constantina Boikos Characterization of Canadian Hospital Infection Control Practices for Caregivers and Visitors Antimicrobial Prescribing Practices in the Treatment of Suspected UTI in the Elderly in the Emergency Department: a Retrospective Single Centre Study The Infectiousness and/or Virulence of Isoniazid-Resistant vs. Susceptible Pulmonary Tuberculosis: A Case-Control Study in Alberta Meropenem MIC Profile of Carbapenemase-Producing Enterobacteriaceae in a Low Prevalence Region Creation of A Novel Pediatric Antimicrobial Stewardship Advanced Fellowship Training Program Emerging Antimicrobial Resistance among Staphylococcus Pseudintermedius, a Potential Zoonoses of Canine Origin Positive Impact of Infectious Disease Consultation on Quality of Care, Mortality and Length of Stay in Staphylococcus aureus Bacteremia: Results from a Large Multicenter Cohort Study Prospective Observational Study of Diagnosis of Urinary Tract Infection and Response to Therapy in Long Term Care Molecular Epidemiology of Vancomycin Heteroresistant Coagulase-Negative Staphylococci in a Neonatal Intensive Care Unit in Quebec Increasing Incidence of Group C and Group G Streptococcal Bacteremia Attributed to Increased Bacterial Virulence Factors and Poor Outcomes Antimicrobial Stewardship in Primary Care: An Evaluation of the Management of Acute Uncomplicated Cystitis in a Family Health Team Withdrawn Clostridium difficile Infections (CDI) in Children: Are we overestimating rates just because of the diagnostic method used? Surveillance of Human Parainfluenza Types 1-4 and Association with Acute Lower Respiratory Tract Infections in Hospitalized Cases, Alberta, Canada (2010 – 2013) Clostridium difficile infection in solid organ transplant recipients at a tertiary care centre during 2006-2013 Safety of the Live-Attenuated Intranasal Influenza Virus (LAIV) Vaccine in Children and Adolescents with Cystic Fibrosis and their Healthy Siblings Serial No. Prog. No. 0058 SP19 Initial Jianbo Last name Zhang 0060 SP20 Élise Fortin 0065 SP21 Kristin Y. Popiel 0066 SP22 Diana Whellams 0068 SP23 Geoffrey Shumilak 0073 SP24 Yan Chen 0077 SP25 Chris Le 0078 SP26 Lauren Goodliffe 0080 SP27 Derek R. MacFadden 0082 SP28 Luke Ryan 0084 SP29 Andrew Denisuik 0085 SP30 Samuel 0086 SP31 0089 SP32 Yannick Sneha De L’ÉtoileMorel Emond Suresh 0090 SP33 Shazia Masud 0091 SP34 Erika Koeck 0092 SP35 Alexandra Mcfarlane 0094 SP36 Galit Pomeranz 0098 SP37 David Harris Title Severe Skin Lesions Induced by a Predominant CA-MRSA Strain USA300 are Associated with a Unique Neutrophil Response and Involvement of Proteinase Activated Receptors (PARs) Surveillance of Antimicrobial Use in Québec Acute Care Hospitals: A Dream or Almost Reality? Usefulness of Fecal Calprotectin and Serum Procalcitonin in Predicting a Positive C. difficile Toxin Gene Polymerase Chain Reaction Assay Successful use of intrathecal colistin in a case of Pseudomonas aeruginosa ventriculitis: a case report and brief review of the literature Prevalence of Anemia in the Saskatchewan Population with HIV Infection Rapid Identification of Bacteria in Positive Blood Cultures Using Smudge Plate Preparation and MALDI-TOF MS System Assessment of the management of suspected urinary tract infections for identification of targeted antimicrobial stewardship interventions Clinical Features and Outcomes of Influenza Infection in Community Dwelling Older Adults Presenting to Six Urban Emergency Departments Engaging Infectious Diseases And Microbiology Residents in Improving the Value of Healthcare: Choosing Wisely Incidence and Outcomes of Hospital-acquired C. difficile Infection at a Large Community Hospital Before and After a Multipronged Prevention and Management Initiative The Continued Rise of Extended-Spectrum β-LactamaseProducing Escherichia coli in Canadian Hospitals: CANWARD 2007-2013 Inpatient Care of Community Acquired Pneumonia: Opportunities for Improvement Feasibility of UV-C light disinfection in a Canadian hospital. Non-Polio Enterovirus Types Associated with Acute Flaccid Paralysis – A Systematic Review Evaluation of Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) for Yeast Identification Xpert MTB/RIF as a Supplemental Test to Acid-Fast Bacilli Sputum Microscopy in the Diagnosis of Tuberculosis: Potential Resource Savings Hospitalized Influenza Patients during 2013-2014; a Comparison of ICU and Ward Treated Patients including Antimicrobial Therapy, Adverse Events, and Outcomes Clinical Spectrum of Rhinovirus Infections in Hospitalized Children in Israel - a single center's experience Prosthetic Joint Infections: Patterns of Practice for Diagnosis, Management, and Outcome Revised April 7, 2015 Page 2 of 6 Serial No. Prog. No. 0100 SP38 0101 SP39 Initial Emilie Amy Last name Vallieres Delorme 0103 SP40 Hilal Al Sidairi 0150 SP41 Claudia 0121 SP42 Byron Martinez de la Peña Berenger 0125 SP43 Angela Ma 0127 SP44 Dahn Jeong 0131 SP45 Alexander Lawandi 0137 SP46 Cindy Lam 0139 SP47 Aaron Campigotto 0144 SP48 Gauri Shah 0145 SP49 William J. Connors Title Urinary Biomarkers in Patients with Cystic Fibrosis Carbon Source Modulates Paradoxical Growth Effect of Caspofungin in Candida albicans Cost-effectiveness of MALDI-TOF MS in Clinical Analysis of Urine Specimens in Nova Scotia Role of Type IV Pili in the Clostridium difficile Pathogenic Program Detection and Characterization of a 2014 Escherichia coli O157:H7 Outbreak in Alberta by Multiple Molecular Methods Including Whole Genome Sequencing Heat Resistant Shiga Toxin-Producing Escherichia coli (STEC) from Clinical Cases in Alberta The Use of Antibiotics in the Treatment of Skin and Soft Tissue Infections in Selected First Nations Communities The Role of Inter-Hospital Sample Transport in Total Assay Time for Microbiological Screening Tests Investigation of Matrix Assisted Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry (MALDI-TOF MS) for detection of Clostridium difficile toxin A and B from stool samples Cumulative antimicrobial susceptibility data from ICUs at one institution: should data be combined? Infectious Complications After Central Venous Catheter Repair in Pediatric Patients Acute Odontogenic Infection Management in the OPAT Clinic Setting: a Quality Improvement Study in Calgary, Alberta Revised April 7, 2015 Page 3 of 6 POSTER PRESENTATION ASSIGNMENT LIST Last name Title Serial Prog. No. No. 0005 P01 Initial Nawal Al Musayeib 0006 P02 Adrian Shephard 0011 P03 Barbara M. Willey 0015 P04 0017 P05 Valan Arasu Mariadhas 0022 P06 Maheen Abidi 0029 P07 0033 P08 Carole Michael Lavigne McConnell 0037 P09 Anthony Bai 0039 P10 Neal Irfan 0041 P11 Khurram Rana 0043 P12 Eugene S. Swenson 0044 P13 Eugene S. Swenson 0053 P14 Hong Yuan Zhou 0054 P15 Min-Kuang Lee 0055 P16 Ramzi Fattouh 0118 P17 Paul N. Levett 0149 P18 Kathleen Whyte 0072 P19 Muhammad Rehan Antiprotozoal potential of phenolic compounds from Kleinia odora In-vitro Antiviral Action of Amylmetacresol (AMC) and 2,4Dichlorobenzyl Alcohol (BCDA) Against the Respiratory Pathogen Parainfluenza Type 3 Use of Temocillin Resistance (TemR) as a Phenotypic Diffusion Marker for Class D Carbapenemases (Carb) in CarbapenemaseProducing Organisms (CPO) Withdrawn Novel Isosteviol Isolated From Pittosporum tetraspermum Exhibited Antimicrobial, Antibiofilm And Anticancer Activities CYP2C19*17 Genetic Polymorphism and Therapeutic Challenges in an Allogeneic Stem Cell Transplant Recipient with Invasive Pulmonary Aspergillosis Nanoparticles to Target HIV Reservoirs Increased Recovery and Detection of Pathogens Using Copan’s WASPLab™ Total Laboratory Automation (TLA) Usefulness of previous methicillin-resistant Staphylococcus aureus screening results in guiding empiric therapy for S. aureus bacteremia Inadequate Symptom Documentation of Urinary Tract Infection in the Medical Chart All-Oral 12-Week Combination Treatment with Daclatasvir (DCV) and Sofosbuvir (SOF) in Patients Infected with HCV Genotype (GT) 3: ALLY-3 Phase 3 Study All-oral, Fixed-dose Combination Therapy with Daclatasvir/Asunaprevir/BMS-791325 for Non-cirrhotic Patients with Chronic HCV Genotype 1 Infection: UNITY-1 Phase 3 SVR12 Results All-oral Fixed-dose Combination Therapy with Daclatasvir/Asunaprevir/BMS-791325, ± Ribavirin, for Patients with Chronic HCV Genotype 1 Infection and Compensated Cirrhosis: UNITY-2 Phase 3 SVR12 Results Recurrent Micafungin-Resistant Candida glabrata Candidemia with Prolonged Micafungin Treatment for Multiple Intraabdominal Abscesses: A Case Report Active Environmental Surveillance of Lyme Disease in British Columbia (2013 and 2014) Investigating the Potential Role of Bacterial Infection in Granulomatosis with Polyangiitis (GPA) Evaluation of antigen detection for confirmatory testing of hepatitis C virus infection Recurrent Invasive Haemophilus influenzae Type a Infection in an Infant Optimizing the Diagnostic Yield of Joint Fluid/ Tissue Culture for Revised April 7, 2015 Page 4 of 6 Serial No. Prog. No. Initial Last name 0097 P20 Jason Leblanc 0099 P21 Melissa Kissoon 0109 P22 Tony Mazzulli 0114 P23 Kimberley Savage 0062 P24 0122 P25 Sarah West 0134 P26 Vanessa 0135 P27 Joel MeierStephenson Kettner 0146 P28 P29 0018 P30 Mary Louise Graham Kamran Kadkhoda 0107 P31 Rabee Adwan 0048 P32 Caroline Quach Title the Hamilton Regional Laboratory Medicine Program Pushing the Limits of Chemistry Point-of-Care Testing for the Management of Patients under Investigation for Ebola Virus Disease Increase in Methicillin-susceptible Staphylococcus aureus with Reduced Susceptibility to Triclosan Over the Last 20 Years Characterizing the resistance related mutations in the NS3 protease of Hepatitis C-infected Ontario patients. Iron Restriction to Clinical Isolates of Candida albicans by DIBI Inhibits Growth and Increases Sensitivity to Azole Antifungals Withdrawn SNAP—Sepsis Now a Priority: Development and Implementation of a Sepsis Algorithm in the Emergency Department of an Academic Hospital What a Fluke: A Case of Biliary Fascioliasis in a Recent Immigrant AMR, Public Health, and Knowledge Translation: A Forward Approach Oversight of Human and Animal Pathogens and Toxins Withdrawn The Retrospective Study of the Prevalence and Clinical Significance of Hepatitis B Virus Precore and Basal Core Promoter Variants Mycoplasma pneumoniae Infection in Children Less Than Five Years of Age; a 17 Years Review Emergency Department Utilization of Respiratory Virus Testing for Febrile Young Infants Under Six Weeks of Age Revised April 7, 2015 Page 5 of 6 Serial No. Serial No. INNOVATION ACADEMY POSTER PRESENTATION LIST Last name Title Prog. No. IA01 Initial Patrick Dolcé IA02 Candy Rutherford IA03 Yanal M. Murad Prog. No. Cv01 Initial Syed Ala CV02 CV03 CV04 Glenn Patriquin Titus Wong Real-Time Computer-Generated Alerts to Select Interventions and Optimize an Antimicrobial Stewardship Program Inclusion of Rhinovirus/Enterovirus in Routine Respiratory Testing Enabled Timely Detection of Enterovirus D68 in the Hamilton Area Preventing C. difficile Infection by Screening Hospital Admissions for C. difficile CLINICAL VIGNETTE POSTER PRESENTATION LIST Last name Title Adenovirus Interstitial Nephritis in a Patient with Renal Transplant A Case of Capnopytophaga canimorsus Meningitis Withdrawn Atypical Case of Atypical Pneumonia: Disseminated Mycoplasma hominis Infection in a Double Lung Transplant Recipient Revised April 7, 2015 Page 6 of 6